Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

These results suggest that in some cases of ER-positive breast carcinoma, tumor cells possibly change from ER-dependent to AR-dependent, rendering them resistant to AI. AR inhibitors may thus be effective in a selected group of patients.